聯合醫務(00722.HK)擬3192.5萬港元購買影像資產及醫療設施
格隆匯5月12日丨聯合醫務(00722.HK)發佈公吿,於2022年5月12日,買方富惠發展有限公司(為公司間接全資附屬公司)與賣方國際醫務中心(香港)有限公司訂立資產購買協議,據此,買方同意購買而賣方同意出售(其中包括)位於有關處所的影像資產及醫療設施,代價為3192.5萬港元。
於2022年5月12日,租户普康醫學影像及化驗中心(中環-華懋中心1期)有限公司(為公司全資附屬公司)與業主就租賃有關處所訂立要約函件,由開始日期起計為期4年。
繼完成資產購買事項及使用權資產收購事項後,集團於有關處所開設一間新一站式先進影像及綜合醫務中心。
董事會相信,資產購買事項將促進集團的長遠發展,增強集團在醫療行業的競爭力。有見及此,為了長遠增長及發展早作籌劃,集團將考慮適時引入其他策略投資者及合作伙伴,彼此共襄合作。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.